Biomarkers of bone turnover in diagnosis and therapy of osteoporosis: a consensus advice from an Austrian working group
- PMID: 22890523
- DOI: 10.1007/s10354-012-0133-9
Biomarkers of bone turnover in diagnosis and therapy of osteoporosis: a consensus advice from an Austrian working group
Abstract
Aim: Reasonable application of laboratory parameters in prevention, diagnosis, treatment and therapy monitoring of osteoporosis.
Target groups: Physicians from different specialist disciplines (general medicine, geriatrics, gynaecology, urology, internal medicine-especially endocrinology and metabolism, nephrology, laboratory medicine, rheumatology, nuclear medicine, orthopaedics, paediatrics, rehabilitation and physical medicine, radiology, social medicine, transplantation medicine, accident surgery), moreover social insurances, hospitals and self-help groups.
Background: Evaluation of aetiology of bone disorders, widening of the therapeutic spectrum for diseases of bone and knowledge on biochemical markers of bone turnover. Improvements in judging the success of therapy and in monitoring the compliance of patients. Research perspectives.
Bases: Scientific literature and guidelines, consensus meetings. RÉSUMÉ: Basic and specialized laboratory investigations are important in differentiation between primary and secondary osteoporosis for an adequate therapy. Biochemical markers of bone turnover are an additional aid in evaluation of individual fracture risk. These markers identify responders to bone therapy faster than surveillance of bone mineral density, which helps to improve patient's compliance too. Characteristics, preanalytic precautions and applications are presented for selected markers of bone resorption and formation and for parameters regulating bone metabolism.
Similar articles
-
[Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].Wien Med Wochenschr. 2023 Oct;173(13-14):299-318. doi: 10.1007/s10354-022-00989-0. Epub 2022 Dec 21. Wien Med Wochenschr. 2023. PMID: 36542221 Free PMC article. Review. German.
-
Updated approach for the management of osteoporosis in Turkey: a consensus report.Arch Osteoporos. 2020 Aug 29;15(1):137. doi: 10.1007/s11657-020-00799-0. Arch Osteoporos. 2020. PMID: 32860546 Free PMC article. Review.
-
The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis.N Engl J Med. 2003 Sep 25;349(13):1207-15. doi: 10.1056/NEJMoa031975. Epub 2003 Sep 20. N Engl J Med. 2003. PMID: 14500804 Clinical Trial.
-
[The role of biochemical markers of bone turnover in the diagnosis of osteoporosis and predicting fracture risk].Tunis Med. 2014 May;92(5):304-10. Tunis Med. 2014. PMID: 25504382 French.
-
Calcium-parathyroid hormone-vitamin D axis and metabolic bone disease in chronic viral liver disease.J Gastroenterol Hepatol. 2001 Sep;16(9):1022-7. doi: 10.1046/j.1440-1746.2001.02561.x. J Gastroenterol Hepatol. 2001. PMID: 11595067
Cited by
-
Prevention and rehabilitation of osteoporosis.Wien Med Wochenschr. 2016 Feb;166(1-2):22-7. doi: 10.1007/s10354-015-0417-y. Epub 2016 Jan 14. Wien Med Wochenschr. 2016. PMID: 26769298 Review.
-
Changing trends in lipid profile and biomarkers of renal function and bone metabolism before and after switching from tenofovir disoproxil fumarate to tenofovir alafenamide: a prospective observational study.AIDS Res Ther. 2021 May 27;18(1):30. doi: 10.1186/s12981-021-00354-y. AIDS Res Ther. 2021. PMID: 34044856 Free PMC article.
-
Expressions and clinical significance of serum bone Gla-protein, bone alkaline phosphatase and C-terminal telopeptide of type I collagen in bone metabolism of patients with osteoporosis.Pak J Med Sci. 2015 Jan-Feb;31(1):91-4. doi: 10.12669/pjms.311.6143. Pak J Med Sci. 2015. PMID: 25878621 Free PMC article.
-
The Role of Monocyte Percentage in Osteoporosis in Male Rheumatic Diseases.Am J Mens Health. 2017 Nov;11(6):1772-1780. doi: 10.1177/1557988317721642. Epub 2017 Sep 13. Am J Mens Health. 2017. PMID: 28901203 Free PMC article.
-
Bisphosphonate drug holiday: choosing appropriate candidates.Curr Osteoporos Rep. 2013 Mar;11(1):45-51. doi: 10.1007/s11914-012-0129-9. Curr Osteoporos Rep. 2013. PMID: 23296595 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical